ArrowMark Colorado Holdings’s Vigil Neuroscience VIGL Stock Holding History

ArrowMark Colorado Holdings’s Portfolio VIGL Stock Details VIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-289,460	Closed	-$2.3M	–	322
2025 Q2	$2.3M	Hold	289,460	–	–	0.04%	226
2025 Q1	$515K	Hold	289,460	–	–	0.01%	270
2024 Q4	$492K	Hold	289,460	–	–	0.01%	280
2024 Q3	$984K	Hold	289,460	–	–	0.01%	248
2024 Q2	$1.16M	Hold	289,460	–	–	0.01%	257
2024 Q1	$987K	Hold	289,460	–	–	0.01%	268
2023 Q4	$978K	Buy	+289,460	New	+$1.49M	0.01%	261

Other funds holding VIGL

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

ArrowMark Colorado Holdings's VIGL Position: Q3 2025 in Review

ArrowMark Colorado Holdings sold out of Vigil Neuroscience (VIGL) in Q3 2025, closing a stake of 289,460 shares — an estimated $2.3M sold.

ArrowMark Colorado Holdings first reported a position in VIGL in Q4 2023 and held it in 7 quarters. The position peaked at $2.3M in Q2 2025. 2 funds tracked by Wall St. Rank hold VIGL as of Q3 2025.

ArrowMark Colorado Holdings reported no remaining Vigil Neuroscience position as of Q3 2025 after selling out during the quarter.
ArrowMark Colorado Holdings sold 289,460 Vigil Neuroscience shares in Q3 2025, an estimated $2.3M.
ArrowMark Colorado Holdings first reported a position in Vigil Neuroscience in Q4 2023 and held it in 7 quarters.
ArrowMark Colorado Holdings's Vigil Neuroscience position peaked at $2.3M in Q2 2025.
2 funds tracked by Wall St. Rank held Vigil Neuroscience as of Q3 2025.

Based on ArrowMark Colorado Holdings's 13F filing for Q3 2025, filed 14 Nov 2025.